Envoy Medical (COCH) Return on Capital Employed (2021 - 2026)
Envoy Medical (COCH) reported Return on Capital Employed of 331.31% for Q1 2026, up 24733.0% on a YoY basis from N/an in Q1 2025, and down 147.49% sequentially from 697.57% in Q4 2025.
Envoy Medical (COCH) Return on Capital Employed (2021 - 2026) Analysis & Trends
Envoy Medical (COCH) has 6 years of Return on Capital Employed data on file, last reported at 331.31% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 24733.0% year-over-year to 331.31%; the trailing twelve-month figure through Mar 2026 stood at 331.31% (up 24733.0% YoY), and the FY2025 full-year result was 1470.94%, up 228463.0% from the prior year.
- Return on Capital Employed slipped to 331.31% in Q1 2026, from 697.57% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4414.68% in Q2 2024 to a low of 38921.9% in Q3 2025.
- A 5-year average of 2106.41% and a median of 40.93% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed jumped 445053 bps in 2024 and tumbled 4105011 bps in 2025, its largest moves.
- Tracing COCH's Return on Capital Employed over 5 years: stood at 3.34% in 2022, then slumped by 2341 bps to 81.41% in 2023, then sank by 707 bps to 657.35% in 2024, then surged by 206 bps to 697.57% in 2025, then slumped by 147 bps to 331.31% in 2026.
- Business Quant data shows COCH's Return on Capital Employed at 331.31% in Q1 2026, 697.57% in Q4 2025, and 38921.9% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | -331.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -331.31% |
| Dec 31, 2025 | 697.57% |
| Sep 30, 2025 | -38,921.90% |
| Jun 30, 2025 | -919.39% |
| Mar 31, 2025 | -578.64% |
| Dec 31, 2024 | -657.35% |
| Sep 30, 2024 | 2,128.20% |
| Jun 30, 2024 | 4,414.68% |
| Mar 31, 2024 | -1,411.53% |
| Dec 31, 2023 | -81.41% |
| Sep 30, 2023 | -40.93% |
| Jun 30, 2023 | -35.85% |
| Mar 31, 2023 | -63.60% |
| Dec 31, 2022 | -3.34% |
| Sep 30, 2022 | -1.22% |
| Jun 30, 2022 | -1.50% |
| Mar 31, 2022 | -1.54% |
| Dec 31, 2021 | -1.41% |